Trupanion (TRUP) Projected to Announce Quarterly Earnings on Thursday

Trupanion (NASDAQ:TRUP) will likely be releasing its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect Trupanion to announce earnings of $0.1633 per share and revenue of $402.53 million for the quarter. Investors can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. The firm had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the firm posted $0.22 EPS. On average, analysts expect Trupanion to post $0.63 EPS for the current fiscal year and $0.70 EPS for the next fiscal year.

Trupanion Stock Performance

Shares of TRUP opened at $30.75 on Tuesday. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. The stock has a market cap of $1.35 billion, a P/E ratio of 55.70, a PEG ratio of 1.77 and a beta of 1.44. The company has a 50-day moving average of $26.88 and a two-hundred day moving average of $26.67. Trupanion has a 12-month low of $21.16 and a 12-month high of $46.98.

Insiders Place Their Bets

In other news, CEO Margaret Tooth sold 1,000 shares of Trupanion stock in a transaction dated Friday, October 9th. The shares were sold at an average price of $25.84, for a total transaction of $25,840.00. Following the completion of the sale, the chief executive officer directly owned 184,952 shares in the company, valued at $4,779,159.68. The trade was a 0.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Fawwad Qureshi sold 6,111 shares of the business’s stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $30.01, for a total transaction of $183,391.11. Following the completion of the transaction, the chief financial officer directly owned 4,230 shares of the company’s stock, valued at approximately $126,942.30. This represents a 59.09% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 14,046 shares of company stock valued at $407,743 in the last ninety days. Insiders own 5.58% of the company’s stock.

Analyst Upgrades and Downgrades

TRUP has been the topic of several research reports. Cantor Fitzgerald lowered their price target on shares of Trupanion from $34.00 to $30.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 7th. Stifel Nicolaus upped their target price on Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a research note on Thursday, August 20th. Piper Sandler cut Trupanion from an “overweight” rating to a “neutral” rating and lowered their target price for the company from $45.00 to $32.00 in a report on Wednesday, August 26th. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 24th. Finally, Atlantic Securities set a $42.00 price target on Trupanion in a report on Wednesday, July 15th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $38.40.

About Trupanion

Trupanion, Inc is a pet insurance company that provides medical insurance coverage for cats and dogs. Its products are designed to help pet owners manage the cost of veterinary care, including coverage for eligible illnesses, injuries and other qualifying medical conditions, subject to the terms of each policy.

The company offers subscription-based pet insurance through the Trupanion brand, with coverage generally intended for ongoing veterinary expenses rather than routine or preventive care.